会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Methods for detecting an analyte of interest using catalyzed reporter deposition of tyramide
    • 使用催化报道沉积酪胺来检测感兴趣分析物的方法
    • US06828109B2
    • 2004-12-07
    • US09738049
    • 2000-12-15
    • David R. Kaplan
    • David R. Kaplan
    • G01N3353
    • G01N33/56972G01N2001/302
    • The present invention relates to methods of staining cells for flow cytometry, using catalyzed reporter deposition and amplification staining. A catalyzed reporter deposition or an analyte dependent enzyme activation system is described for detecting and/or quantitating an analyte of interest in or on a cell by flow cytometry. Also described are compositions for use in catalyzed reporter deposition methods that can be used to reduce background staining, and thereby enhance peak signal separation between histograms obtained from cells stained with control immunoglobulin versus cells stained with immunoglobulin specific for an analyte of interest, in catalyzed deposition methods.
    • 本发明涉及使用催化报道沉淀和扩增染色染色细胞的流式细胞术的方法。 描述了催化的报告沉积或分析物依赖性酶活化系统,用于通过流式细胞术检测和/或定量细胞中或细胞上的目标分析物。 还描述了用于催化报道沉积方法的组合物,其可用于减少背景染色,从而增强从对照免疫球蛋白染色的细胞获得的直方图与感兴趣的分析物的免疫球蛋白染色的催化沉积中的峰信号分离 方法。
    • 8. 发明授权
    • HIV envelopolype peptides
    • HIV包膜蛋白肽
    • US06806055B2
    • 2004-10-19
    • US09966931
    • 2001-09-27
    • Phillip W. BermanGerald R. Nakamura
    • Phillip W. BermanGerald R. Nakamura
    • G01N3353
    • C07K14/005A61K39/00C07K16/1063C07K2317/34C12N2740/16122
    • A method for the rational design and preparation of vaccines based on HIV envelope polypeptides is described. In one embodiment, the method for making an HIV gp120 subunit vaccine for a geographic region comprises determining neutralizing epitopes in the V2 and/or C4 domains of gp120 of HIV isolates from the geographic region and selecting an HIV strain having gp120 a neutralizing epitope in the V2 or C4 domain which is common among isolates in the geographic region. In a preferred embodiment of the method, neutralizing epitopes for the V2, V3, and C4 domains of gp120 are determined. At least two HIV isolates having different neutralizing epitopes in the V2, V3, or C4 domain are selected and used.to make the vaccine. The invention also provides a multivalent HIV gp120 subunit vaccine. A DNA sequence encoding gp120 from preferred vaccine strains of HIV, GNE8 and GNE16, expression constructs comprising the GNE8-gp120 and GNE16-gp120 encoding DNA under the transcriptional and translational control of a heterologous promoter, and isolated GNE8-gp120 and GNE16-gp120 are also described.
    • 描述了基于HIV包膜多肽合理设计和制备疫苗的方法。 在一个实施方案中,用于制备用于地理区域的HIV gp120亚单位疫苗的方法包括测定来自地理区域的HIV分离物的gp120的V2和/或C4结构域中的中和表位,并且选择具有gp120的HIV株, V2或C4结构域,这在地理区域中是分离的。 在该方法的优选实施方案中,测定gp120的V2,V3和C4结构域的中和表位。 选择并使用至少两个在V2,V3或C4结构域中具有不同中和表位的HIV分离物来制备疫苗。 本发明还提供了一种多价HIV gp120亚单位疫苗。 编码来自HIV,GNE8和GNE16的优选疫苗株的gp120的DNA序列,在异源启动子和分离的GNE8-gp120和GNE16-gp120的转录和翻译控制下,包含编码DNA的GNE8-gp120和GNE16-gp120的表达构建体是 也描述。